Clinical Trials Logo
  1. Home
  2. Parasitic Diseases
  3. NCT01050517

Safety and Efficacy of Drug Combinations Against Triple Infections

Parasitic Diseases Clinical Trial

Official title:
Gaps in Helminth Control: Safety and Efficacy of Drug Combinations Against Triple Infections

Clinical Trial Summary

This randomised, controlled, double blinded clinical study investigates the safety and efficacy of the combination of albendazole, ivermectin and praziquantel in the treatment of children aged 5-18 years co-infected with lymphatic filariasis, schistosomiasis and soil-transmitted helminthiasis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01050517
Study type Interventional
Source DBL -Institute for Health Research and Development
Contact
Status Completed
Phase N/A
Start date October 2007
Completion date December 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT01050374 - Safety and Efficacy of Drug Combinations Against Schistosomiasis N/A
Completed NCT01050452 - Safety and Efficacy of Drug Combinations Against Trichuris Trichiura N/A
Recruiting NCT00344188 - Diagnosis and Treatment of Leishmania Infections
Active, not recruiting NCT02653898 - Malaria Elimination Pilot Study in Military Forces in Cambodia Phase 4
Completed NCT01425073 - Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya N/A
Completed NCT01533961 - Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 Phase 1
Completed NCT01586169 - Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination N/A
Completed NCT05979207 - Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum Phase 1